Fidelity Investments’s iSpecimen ISPC Stock Holding History

Fidelity Investments’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8	Closed	-$387	–	5502
2025 Q3	$387	Buy	+8	New	+$376	﹤0.01%	5109

Other funds holding ISPC

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Fidelity Investments's ISPC Position: Q4 2025 in Review

Fidelity Investments sold out of iSpecimen (ISPC) in Q4 2025, closing a stake of 8 shares — an estimated $387 sold.

Fidelity Investments first reported a position in ISPC in Q3 2025 and held it in 1 quarter. The position peaked at $387 in Q3 2025. 9 funds tracked by Wall St. Rank hold ISPC as of Q4 2025.

Fidelity Investments reported no remaining iSpecimen position as of Q4 2025 after selling out during the quarter.
Fidelity Investments sold 8 iSpecimen shares in Q4 2025, an estimated $387.
Fidelity Investments first reported a position in iSpecimen in Q3 2025 and held it in 1 quarter.
Fidelity Investments's iSpecimen position peaked at $387 in Q3 2025.
9 funds tracked by Wall St. Rank held iSpecimen as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.